U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H12N2O5S
Molecular Weight 272.278
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 7-AMINOCEPHALOSPORANIC ACID

SMILES

[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2N)C(O)=O

InChI

InChIKey=HSHGZXNAXBPPDL-HZGVNTEJSA-N
InChI=1S/C10H12N2O5S/c1-4(13)17-2-5-3-18-9-6(11)8(14)12(9)7(5)10(15)16/h6,9H,2-3,11H2,1H3,(H,15,16)/t6-,9-/m1/s1

HIDE SMILES / InChI
Molecular Formula C10H12N2O5S
Molecular Weight 272.278
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

7-aminocephalosporanicacid (7-ACA) is convenient starting material for the industrial production of various kinds of semisynthetic cephalosporin antibiotics. In many cases, chemical modifications at the C-7 position is required. Industrially, 7-ACA is derived by chemical or enzymatic deacylation from cephalosporin C, which is fermentatively produced by Acremonium chrysogenum. 7-ACA is a stable only at neutral pHs, enzymatic manipulations are desirable for chemical modifications in the production of cephalosporin related compounds.

Originator

Pfizer
420
Curator's Comment: # Pfizer & Co C

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Substrate
661
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
[Thoughts on explaining cigarette smoking].
1987 Feb
Improvement of the synthesis of diphenylmethyl 7beta-(o-hydroxy)benzylideneamino-3-hydroxymethyl-3-cephem-4-carboxylate.
2001 Aug
Active site residues of cephalosporin acylase are critical not only for enzymatic catalysis but also for post-translational modification.
2001 Dec 21
A rapid and specific method to screen environmental microorganisms for cephalosporin acylase activity.
2003 Jul
The kinetic properties of the carboxy terminal domain of the Bacillus licheniformis 749/I BlaR penicillin-receptor shed a new light on the derepression of beta-lactamase synthesis.
2003 Jun
Industrial production of beta-lactam antibiotics.
2003 Jun
Synthesis and preliminary antimicrobial evaluation of new 7-(N-pyrrolyl) derivatives of cephalosporins.
2004
Batch production of deacetyl 7-aminocephalosporanic acid by immobilized cephalosporin-C deacetylase.
2004 Aug
Catalytic properties of D-amino acid oxidase in cephalosporin C bioconversion: a comparison between proteins from different sources.
2004 Mar-Apr
D-Amino acid oxidase: structure, catalytic mechanism, and practical application.
2005 Jan
Enzymatic modifications of cephalosporins by cephalosporin acylase and other enzymes.
2006 Apr-Jun
Thermal inactivation of D-amino acid oxidase from Trigonopsis variabilis occurs via three parallel paths of irreversible denaturation.
2006 Jul 5
Enzymatic synthesis of cephalosporins. The immobilized acylase from Arthrobacter viscosus: a new useful biocatalyst.
2007 Dec
Construction of recombinant Escherichia coli D11/pMSTO and its use in enzymatic preparation of 7-aminocephalosporanic acid in one pot.
2007 May 1
[7-aminocephalosporanic acid induced bronchial asthma in two patients].
2007 Oct
Site-specific protonation microequilibria of penicillin and cephalosporin beta-lactam core molecules.
2007 Sep
Enhancement of glutaryl-7-aminocephalosporanic acid acylase activity of gamma-glutamyltranspeptidase of Bacillus subtilis.
2010 Aug
Occupational asthma in Korea.
2010 Dec
Biosynthesis of cephalosporin-C acylase enzyme: optimal media design, purification, and characterization.
2010 Oct
Patents

Patents

JP1056682A
1
JP1090190A
1
JP2001507688A
24
JP2001525667A
12
JP2002000266A
1
JP2005198655A
1
JP2005348743A
1
JP3903392B2
18
JPH00453499A
1
JPH00568551A
1
JPH00584077A
1
JPH00584078A
1
JPH00898683A
1
JPH00898686A
1
JPH01131182A
1
JPH02160791A
1
JPH022396A
1
JPH0242085A
1
JPH02456A
1
JPH04104792A
1
JPH04198184A
1
JPH04211088A
1
JPH04230689A
1
JPH0453499A
1
JPH05211889A
1
JPH05211890A
1
JPH0568551A
1
JPH0584077A
1
JPH0584078A
1
JPH06141857A
1
JPH06184161A
1
JPH06225794A
1
JPH0646835A
1
JPH0680673A
1
JPH0690746A
1
JPH07145173A
1
JPH07165765A
1
JPH07222587A
1
JPH07303483A
1
JPH07313161A
1
JPH08224089A
1
JPH08242884A
1
JPH08256789A
1
JPH08301874A
1
JPH0898683A
1
JPH0898686A
1
JPH0948784A
1
JPH10291991A
1
JPH10291993A
1
JPH1160583A
1
JPS05238092A
4

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:01:59 GMT 2023
Edited
by admin
on Fri Dec 15 15:01:59 GMT 2023
Record UNII
9XI67897RG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
7-AMINOCEPHALOSPORANIC ACID
MI  
Common Name English
CEFTRIAXONE SODIUM IMPURITY E [IP]
Common Name English
CEFAZOLIN SODIUM IMPURITY H [EP IMPURITY]
Common Name English
7-ACA
Common Name English
3-(ACETOXYMETHYL)-7-AMINOCEPHEM-4-CARBOXYLIC ACID
Common Name English
CEFOPERAZONE SODIUM IMPURITY E [EP IMPURITY]
Common Name English
(7R)-7-AMINOCEPHALOSPORANIC ACID
Common Name English
7.BETA.-AMINO-3-ACETOXYMETHYLCEPHEMCARBOXYLIC ACID
Common Name English
(6R,7R)-3-((ACETYLOXY)METHYL)-7-AMINO-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID
Systematic Name English
3-ACETOXYMETHYL-7.BETA.-AMINOCEPH-3-EM-4-CARBOXYLIC ACID
Common Name English
7.BETA.-AMINOCEPHALOSPORANIC ACID
Common Name English
5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 3-((ACETYLOXY)METHYL)-7-AMINO-8-OXO-, (6R,7R)-
Systematic Name English
7-AMINOCEPHALOSPORANIC ACID [MI]
Common Name English
7-Aminocephalosporanic acid [WHO-DD]
Common Name English
Code System Code Type Description
FDA UNII
9XI67897RG
Created by admin on Fri Dec 15 15:01:59 GMT 2023 , Edited by admin on Fri Dec 15 15:01:59 GMT 2023
PRIMARY
ECHA (EC/EINECS)
213-485-0
Created by admin on Fri Dec 15 15:01:59 GMT 2023 , Edited by admin on Fri Dec 15 15:01:59 GMT 2023
PRIMARY
CHEBI
2255
Created by admin on Fri Dec 15 15:01:59 GMT 2023 , Edited by admin on Fri Dec 15 15:01:59 GMT 2023
PRIMARY
MERCK INDEX
m1699
Created by admin on Fri Dec 15 15:01:59 GMT 2023 , Edited by admin on Fri Dec 15 15:01:59 GMT 2023
PRIMARY Merck Index
PUBCHEM
441328
Created by admin on Fri Dec 15 15:01:59 GMT 2023 , Edited by admin on Fri Dec 15 15:01:59 GMT 2023
PRIMARY
CAS
957-68-6
Created by admin on Fri Dec 15 15:01:59 GMT 2023 , Edited by admin on Fri Dec 15 15:01:59 GMT 2023
PRIMARY
MESH
C030735
Created by admin on Fri Dec 15 15:01:59 GMT 2023 , Edited by admin on Fri Dec 15 15:01:59 GMT 2023
PRIMARY
WIKIPEDIA
7-ACA
Created by admin on Fri Dec 15 15:01:59 GMT 2023 , Edited by admin on Fri Dec 15 15:01:59 GMT 2023
PRIMARY
EPA CompTox
DTXSID9045342
Created by admin on Fri Dec 15 15:01:59 GMT 2023 , Edited by admin on Fri Dec 15 15:01:59 GMT 2023
PRIMARY
Related Record Type Details
Structure of CEFAZOLIN
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of CEFOPERAZONE SODIUM
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of CEFTRIAXONE SODIUM
PARENT -> IMPURITY
Structure of CEFTIOFUR HYDROCHLORIDE
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of CEFAZOLIN SODIUM
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of CEFAZOLIN SODIUM
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of CEFOTAXIME SODIUM
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966